{"id":"W2999877370","doi":"10.1128/aac.02177-19","title":"Activity of Meropenem-Vaborbactam against Bacterial Isolates Causing Pneumonia in Patients in U.S. Hospitals during 2014 to 2018","year":2020,"lang":"en","type":"article","venue":"Antimicrobial Agents and Chemotherapy","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"bioMérieux; Dr. Falk Pharma; Idorsia Pharmaceuticals; Wockhardt; TenNor Therapeutics; Astellas Foundation for Research on Metabolic Disorders; Shionogi; Basilea Pharmaceutica; Astellas Pharma; Pfizer; Melinta Therapeutics; Entasis Therapeutics; Albany College of Pharmacy and Health Sciences; Achaogen; Amplyx; University of North Texas; Medicines Company; Roivant Sciences; Nabriva Therapeutics; BD; GenePOC; Boston Pharmaceuticals; Novartis; Harvard University; F. Hoffmann-La Roche; Allergan; Cidara Therapeutics; University of Southern California; GlaxoSmithKline; Bayer","keywords":"Pseudomonas aeruginosa; Meropenem; Pneumonia; Medicine; Broth microdilution; Microbiology; Ventilator-associated pneumonia; Bacterial pneumonia; Antibiotics; Biology; Internal medicine; Bacteria; Antibiotic resistance; Minimum inhibitory concentration; Genetics","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004589038,0.0002680754,0.0004218608,0.0003966797,0.0002114206,0.000484376,0.0001606691,0.0002594106,0.0006059842],"category_scores_gemma":[0.001211185,0.0001660896,0.0002622881,0.0004736236,0.0001642706,0.0003388287,0.0002850567,0.0003409989,0.00009986621],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004644835,"about_ca_system_score_gemma":0.0005563091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00464887,"about_ca_topic_score_gemma":0.00854284,"domain_scores_codex":[0.9995747,0.00008568409,0.00007834341,0.00009694437,0.00009777891,0.00006655808],"domain_scores_gemma":[0.9994459,0.00008493729,0.0001483764,0.00001678297,0.0001989359,0.0001050691],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.008024523,0.0009693686,0.8107269,0.0005759145,0.0004267362,0.0007668994,0.0008853832,0.001095113,0.09920143,0.0001255039,0.002358044,0.07484419],"study_design_scores_gemma":[0.0001478516,0.00454222,0.9690062,0.00009904492,0.0001730994,0.0008303653,0.0006434861,0.0006491911,0.01969613,0.00003725903,0.004151418,0.00002380615],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99717,0.001491723,0.00006239385,0.00007469419,0.00001514571,0.00002377894,0.0006606784,0.000009785726,0.0004917211],"genre_scores_gemma":[0.9979809,0.0005339873,0.000191718,0.00009585366,0.00001595919,0.00001364561,0.0008705327,0.00000304584,0.0002943987],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00464887,"threshold_uncertainty_score":0.009243608,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005320089047802427,"score_gpt":0.2202602917084915,"score_spread":0.2149402026606891,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}